Department of Nuclear Medicine, Peking University People's Hospital, 11th Xizhimen South St., Beijing, 100044, China.
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
Clin Rheumatol. 2017 Oct;36(10):2297-2305. doi: 10.1007/s10067-017-3794-3. Epub 2017 Aug 22.
This study aimed to investigate the multiple values of F-FDG PET/CT in detecting malignant tumors, evaluating myopathy, and determining interstitial lung disease in patients with idiopathic inflammatory myopathy (IIM). We retrospectively analyzed the data of 38 patients who were examined by F-FDG PET/CT and eventually diagnosed as IIM. We also collected the data of another 22 cases with negative PET/CT as the control. Pulmonary HRCT images were acquired simultaneously with regular F-FDG PET/CT imaging for each patient. Image analysis included the presence of malignant lesions, muscular FDG uptake, and interstitial lung disease and its imaging features. IIM was classified into polymyositis (PM), classic dermatomyositis (CDM), and clinical amyopathic dermatomyositis (CADM). All suspected malignant lesions were confirmed by histopathological examination. Interstitial lung disease was diagnosed by HRCT. Rapidly progressive interstitial lung disease (RP-ILD) was determined according to clinical follow-ups. The significance of F-FDG PET/CT in the detection of malignancy, observation of activity of myopathy, and determination of interstitial lung disease in IIM patients was explored based on the final clinical diagnosis. In the 38 patients with IIM, 3 cases were classified as PM, 18 as CDM, and 17 as CADM. PET/CT correctly detected 7 cases (18.4%) of malignant tumors, and all of which were found in CDM and PM patients. The muscular FDG uptake in IIM patients was higher than the control population, and it was higher in patients with myopathy (including PM and CDM) than in patients with CADM. The muscular FDG uptake in IIM patients was correlated with elevated serum creatine kinase level (r = 0.332, P = 0.042) and impaired muscle strength (r = -0.605, P < 0.001). Interstitial lung disease was detected by HRCT in 30 patients (78.9%), and 7 of them were eventually confirmed as RP-ILD, according to the clinical outcome. The FDG uptake in lung lesions of RP-ILD patients was higher than those with chronic interstitial lung diseases, even though no significant difference was found between the CT features of RP-ILD and chronic interstitial lung disease. When SUV ≥ 2.4 was employed as the threshold for RP-ILD prediction, the diagnostic efficiency was yield with a sensitivity of 100.0% (7/7), specificity of 87.0% (20/23), and accuracy of 90.0% (27/30), respectively. For IIM patients, F-FDG PET/CT has multiple values in identifying malignancies, observing the status of inflammatory myopathy, detecting interstitial lung disease, and predicting the occurrence of RP-ILD. Therefore, it is recommended to use PET/CT in the clinical course of diagnosis and management of IIM.
本研究旨在探讨 F-FDG PET/CT 在检测恶性肿瘤、评估肌病和确定特发性炎症性肌病(IIM)患者间质性肺病中的多重价值。我们回顾性分析了 38 例经 F-FDG PET/CT 检查并最终诊断为 IIM 的患者的数据。我们还收集了另外 22 例 PET/CT 阴性的病例作为对照。为每位患者同时采集常规 F-FDG PET/CT 成像的肺部高分辨率 CT(HRCT)图像。图像分析包括恶性病变、肌肉 FDG 摄取以及间质性肺病及其影像学特征的存在。IIM 分为多发性肌炎(PM)、经典皮肌炎(CDM)和临床无肌病性皮肌炎(CADM)。所有疑似恶性病变均经组织病理学检查证实。间质性肺病通过 HRCT 诊断。根据临床随访,确定快速进展性间质性肺病(RP-ILD)。根据最终临床诊断,探讨 F-FDG PET/CT 在 IIM 患者恶性肿瘤检测、肌病活动观察和间质性肺病诊断中的意义。在 38 例 IIM 患者中,3 例为 PM,18 例为 CDM,17 例为 CADM。PET/CT 正确检测到 7 例(18.4%)恶性肿瘤,均在 CDM 和 PM 患者中发现。与对照组相比,IIM 患者的肌肉 FDG 摄取量较高,且在肌病(包括 PM 和 CDM)患者中高于 CADM 患者。与 CADM 患者相比,IIM 患者肌肉 FDG 摄取量与血清肌酸激酶水平升高(r=0.332,P=0.042)和肌肉力量下降(r=-0.605,P<0.001)相关。30 例患者(78.9%)通过 HRCT 检测到间质性肺病,其中 7 例根据临床结果最终确诊为 RP-ILD。RP-ILD 患者肺部病变的 FDG 摄取量高于慢性间质性肺病患者,尽管 RP-ILD 和慢性间质性肺病的 CT 特征之间没有显著差异。当 SUV≥2.4 作为预测 RP-ILD 的阈值时,诊断效率的灵敏度为 100.0%(7/7),特异性为 87.0%(20/23),准确性为 90.0%(27/30)。对于 IIM 患者,FDG PET/CT 在识别恶性肿瘤、观察炎症性肌病状态、检测间质性肺病和预测 RP-ILD 发生方面具有多重价值。因此,建议在 IIM 的诊断和管理过程中使用 PET/CT。